Type 1 diabetes (T1D) is estimated to affect 100,000 children every year worldwide. There were nine million T1D patients in the world in 2017. T1D patients need to monitor blood glucose levels regularly and administrate insulin to manage their blood glucose levels. Moreover, new immunotherapies, personalized gene and stem cell therapies, and non-immunomodulatory adjunctive are being developed to manage T1D.
To gain detailed insights into the latest trends in T1D management, join reputed Diabetologists and Endocrinologists in our exclusive webinar on 17 th May 2026, 8:00 PM IST onwards . Stay tuned! ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no warranties, explicit or implied, about the suitability, reliability, or adequacy of the information, including data visualization elements and…
